Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors

The potential for adoptive cell immunotherapy as a treatment against cancers has been demonstrated by the remarkable response in some patients with hematological malignancies using autologous T cells endowed with chimeric antigen receptors (CARs) specific for CD19. Clinical efficacy of CAR-T cell th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Erhao, Gu, Jieyi, Xu, Hanmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767005/
https://www.ncbi.nlm.nih.gov/pubmed/29329591
http://dx.doi.org/10.1186/s12943-018-0759-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767005/
https://www.ncbi.nlm.nih.gov/pubmed/29329591
http://dx.doi.org/10.1186/s12943-018-0759-3

Ejemplares similares